LON:SER 5533861 (SER.L) (SER) Share Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisBuy This Stock About 5533861 (SER.L) Stock (LON:SER) 30 days 90 days 365 days Advanced Chart Get 5533861 (SER.L) alerts:Sign Up Key Stats Today's Range N/A50-Day Range N/A52-Week Range N/AVolumeN/AAverage Volume60.79 million shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Sefton Resources, Inc. is a United States-based company, which is engaged in the exploration, development and production of oil and natural gas. The Company is also engaged in gathering and transporting natural gas in the Continental United States. The Company's properties are located in California and Kansas, the United States. It has approximately 40,000 acres in the Forest City Basin of Eastern Kansas to develop Coal Bed Methane gas, as well as conventional oil and gas projects. The Company also owns a transmission pipeline in Kansas. The Company's subsidiaries include TEG MidContinent and TEG Transmission. Read More Receive SER Stock News and Ratings via Email Sign-up to receive the latest news and ratings for 5533861 (SER.L) and its competitors with MarketBeat's FREE daily newsletter. Email Address SER Stock News HeadlinesSerina Therapeutics Advances POZ-VMAT2i into Development for Tardive Dyskinesia (TD)July 29, 2025 | globenewswire.comSerina Therapeutics to Present at the BTIG Virtual Biotechnology ConferenceJuly 28, 2025 | globenewswire.comIs America’s Everything Bubble About to Burst?On July 4th, Trump signed the “One Big Beautiful Bill,” adding $3.4 trillion to the national debt — and pushing America’s debt-to-GDP ratio to 175%. Top investors are warning of an epic bubble bursting soon. A free guide reveals how to shield your 401(k), savings, and portfolio before the collapse. | American Alternative (Ad)Serina Therapeutics Makes Grant to New Employee Under Inducement PlanJuly 10, 2025 | globenewswire.comSerina Therapeutics Announces Date for 2025 Annual Stockholders MeetingJuly 1, 2025 | globenewswire.comSerina Therapeutics to Present at FORCE Family Office Investor Webinar on June 26, 2025June 23, 2025 | globenewswire.comUPDATED: Serina Therapeutics Congratulates Juvenescence Ltd. on $76M First Tranche Close of Series B Funding and Strategic Partnership with M42June 17, 2025 | globenewswire.comSerina Therapeutics Congratulates Juvenescence Ltd. on $150M Series B Funding and Strategic Partnership with M42June 17, 2025 | globenewswire.comSee More Headlines SER Stock Analysis - Frequently Asked Questions How do I buy shares of 5533861 (SER.L)? Shares of SER stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock. What other stocks do shareholders of 5533861 (SER.L) own? Based on aggregate information from My MarketBeat watchlists, some other companies that 5533861 (SER.L) investors own include Serco Group (SRP), Sosandar (SOS), Cadence Minerals (KDNC), Gulf Keystone Petroleum (GKP) and Echo Energy (ECHO). Industry, Sector and Symbol Stock ExchangeLON SectorManufacturing Industry Pharmaceutical Preparations Sub-IndustryPharmaceutical Products Current SymbolLON:SER CIKN/A Webwww.seftonresources.com Phone+44-20-78725570FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A Reduce the RiskMarket downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.Get This Free Report This page (LON:SER) was last updated on 8/3/2025 by MarketBeat.com Staff From Our PartnersMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | SponsoredIf you saw this, you'd be scared tooMarkets may look strong—but one veteran analyst warns we’re nearing a financial breaking point. After 40+ y...InvestorPlace | SponsoredUtah’s New Oil FindThe Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle ...Stansberry Research | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredChina just unlocked Nvidia’s AI chips—what that means for youTired of Missing Big AI Moves Like Nvidia? You’re not the problem—your trading system is. Tim’s XGPT system...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding 5533861 (SER.L) Please log in to your account or sign up in order to add this asset to your watchlist. Share 5533861 (SER.L) With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.